SRF (Serum Response Factor) activators belong to a distinctive chemical class recognized for their capacity to modulate the activity of SRF, a transcription factor that plays a central role in regulating gene expression patterns involved in cell growth, proliferation, and differentiation. These activators function by influencing the interactions and pathways involving SRF, which binds to specific DNA sequences known as serum response elements (SREs) to regulate the expression of genes critical for cellular responses to various extracellular signals. SRF is pivotal in orchestrating processes such as embryogenesis, tissue development, and response to mechanical cues, making it a key player in maintaining cellular homeostasis and adapting to changing environmental conditions. SRF activators are thoughtfully designed to target specific mechanisms or pathways associated with SRF, thus influencing its cellular functions and downstream effects on gene expression and cellular responses.
The development of SRF activators necessitates a comprehensive understanding of the structural attributes of SRF and its interactions with DNA, co-factors, and other transcriptional regulators. Researchers in this field work to engineer molecules that promote the activation of SRF, contributing to its role in modulating gene transcription and cellular behaviors. These activators often employ innovative design strategies that enhance SRF's functional role in coordinating cellular responses to extracellular signals and modulating gene expression profiles. By gaining insights into the intricate mechanisms through which SRF participates in various cellular processes, researchers aim to unravel its significance in fundamental biological phenomena. Ongoing advancements in molecular pharmacology and chemical synthesis drive the refinement of SRF activators, offering applications across diverse scientific domains where manipulation of SRF-mediated processes is of interest.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
An antibiotic that at low concentrations, can activate SRF by interfering with G-actin availability. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $230.00 | ||
An enzyme that activates blood clotting, it can induce SRF activation through downstream signaling pathways. | ||||||
L-phenylephrine | 59-42-7 | sc-295315 sc-295315A | 5 g 25 g | $177.00 $482.00 | 2 | |
A sympathomimetic suggested compound, it can activate SRF in certain cell types by engaging adrenergic receptors. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
A compound that increases cyclic AMP levels, activating SRF through the cAMP-PKA pathway. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a potent and broad-spectrum HDAC inhibitor. It interferes with the activity of histone deacetylases, leading to increased histone acetylation and chromatin accessibility. This, in turn, can activate gene transcription, including the activation of SRF-regulated genes. | ||||||